Biomarker driven treatment of selected NSCLC: EGFR; EGFR TKI in mutant EGFR NSCLC; Mechanisms of resistance and drugs in development

Date 16 December 2015
Event ESMO Preceptorship on NSCLC, Singapore
Session Session 5 - Biomarker driven treatment
Topics Lung and other Thoracic Tumours
Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Y.L. WU, CN